The Annexure

News to 9 October 2026 ·

Desk›Diversified› Lords Mark Industries Ltd

Lords Mark Industries Ltd

BSE 501261 · NSE LORDSMARK · ISIN INE567L01025 · Group XT · Active

Diversified › Diversified › Diversified › Diversified

₹80.35

-0.66%

BSE close, 28 August 2026

Market cap

₹3,427.91 cr

42.7 cr shares · Micro cap

Free float

₹1,748.06 cr

as published

P/E · P/B

40.4× · 892.78×

EPS ₹1.99 · BV ₹0.09

FY25-26 rev / PAT

601.71 / 52.76

₹ cr, as filed

Filings, window

36

11 selected · 31%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹60.00 52-WK HIGH ₹669.70 ₹80.35 3% of range
Against 52-week high-88.0%
Against 52-week low+33.9%
Day change-0.66%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹1.99
Price / earnings40.38×
Price / book892.78×
Book value — derived, price ÷ P/B₹0.09
Return on equity2,124.05%
Operating margin18.21%
Net margin11.47%

Consistency check

P/B ÷ P/E, which must equal ROE
2,210.95%
ROE as published
2,124.05%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 280.36 32.16 0.75 18.21% 11.47%
Mar-26 · Q 441.98 41.22 0.97 14.03% 9.33%
FY25-26 601.71 52.76 1.24 14.59% 8.77%

Quarter on quarter

Revenue, quarter on quarter
-36.6%
Net profit, quarter on quarter
-22.0%
Operating margin, quarter on quarter
+418 bps

Disclosure profile 36 filings in the window

0 median 13.5 p75 · 19 sector max 36 36 100th percentile of 16 Diversified filers
Shaded is the middle half of the sector, 10 to 19 filings. Measured against the 16 Diversified companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Investor Presentation5
Board Outcome2
Credit Rating1
KMP1
Order / Contract1
Results1
Selected sub-total11
Procedural
General16
SAST3
AGM / EGM2
Allotment1
Board Meeting1
Compliance Certificate1
Trading Window1
Procedural sub-total25
Total36

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group XT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

36 filings · 11 selected · busiest 2026-08-13

Filing rhythm · the twelve most recent

2026-09-232026-10-06

SelectedProcedural

Filings

36 in the window · 18 earlier on record

  1. 6 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    September 2026 certificate

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 5 October 2026 ·

    General

    Intimation Titled -Lord'S Mark Industries Limited Receives MHRA Registration For IVD Portfolio; UK Commercial Sales To Begin December 2026

    Update regarding MHRA Registration for IVD portfolio..

    Company Update / General View filing →

  3. 1 October 2026 ·

    General

    Re-Investment Of Funds Received From Sale Of 89,98,598 Equity Shares By Promoter Mr. Sachidanand Hariram Upadhyay For Medical Device Unit Expansion Of The Company.

    Re-investment of funds received from sale of 89,98,598 Equity shares by Promoter Mr. Sachidanand Hariram Upadhyay for Medical Device Unit Expansion of the company.

    Company Update / General View filing →

  4. 1 October 2026 ·

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachidanant Upadhyay

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  5. 1 October 2026 ·

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachidanand Upadhyay

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  6. 30 September 2026 ·

    General

    Intimation Regarding Achievement Of Minimum Public Shareholding (MPS) Of 25% Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Achieved MPS of 25%

    Company Update / General View filing →

  7. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Voting results and Scrutinizer report

    AGM/EGM / AGM View filing →

  8. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceeding of AGM held on 30-09-2026

    AGM/EGM / AGM View filing →

  9. 29 September 2026 ·

    Trading Window

    Closure of Trading Window

    Trading window closure for September results

    Insider Trading / SAST / Closure of Trading Window View filing →

  10. 28 September 2026 ·

    General

    Intimation Titled 'From An Indian Innovation To A Global Renal-Care Opportunity: Lord'S Mark Industries Takes Its AI-Powered Dialysis Ecosystem Closer To International Markets'

    AI powered dialysis update

    Company Update / General View filing →

  11. 24 September 2026 ·

    General

    Intimation Regarding Confirmation And Proposal Received From Promoter, Mr. Sachidanand Hariram Upadhyay For Re-Investment Of Funds Received From Sale Of Equity Shares Of The Company For Medical Device Unit Expansion.

    Intimation U/R 30

    Company Update / General View filing →

  12. 23 September 2026 ·

    General

    Intimation Titled 'Technical Committee Approves Final Clinical Trial Stage; Company Targets Regulatory Clearances And Commercial Launch By April 2027'

    Intimation under regulation 30 regarding AI - Powered Breast Cancer Screening Technology towards final clinical trials

    Company Update / General View filing →

  13. 22 September 2026 ·

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachidanand Hariram Upadhyay

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  14. 16 September 2026 ·

    General

    Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Completion Of Phase I Expansion At Silvassa Facility Ahead Of Schedule.

    Completion of Phase I expansion at Silvassa Facility

    Company Update / General View filing →

  15. 15 September 2026 ·

    Investor Presentation

    Investor Presentation

    Highlights of investor's meet

    Company Update / Investor Presentation View filing →

  16. 10 September 2026 ·

    Investor Presentation

    Investor Presentation

    Audio and Video recording of Investor's meet

    Company Update / Investor Presentation View filing →

  17. 9 September 2026 ·

    General

    The Company Has Been Invited To Attend Investor Summit Being Organized By Financial Mindss (A Jaibharti Group Co.)

    Investor Meet update

    Company Update / General View filing →

  18. 24 August 2026 ·

    General

    Subject: Disclosure Regarding Strategic Collaboration With ARKALL Holdings Limited For Healthcare Expansion Across The Caribbean Region

    Strategic Collaboration with ARKALL Holdings Ltd

    Company Update / General View filing →

  19. 21 August 2026 ·

    Investor Presentation

    Investor Presentation

    Transcript of investor conference call

    Company Update / Investor Presentation View filing →

  20. 20 August 2026 ·

    Investor Presentation

    Investor Presentation

    Audio Video Recording of investor call

    Company Update / Investor Presentation View filing →

  21. 18 August 2026 ·

    Credit Rating

    Credit Rating

    Credit Rating revised

    Company Update / Credit Rating View filing →

  22. 17 August 2026 ·

    Investor Presentation

    Investor Presentation

    Company has been appointed to meet investor summit

    Company Update / Investor Presentation View filing →

  23. 17 August 2026 ·

    General

    News Paper Publishment

    News Paper Publishment for 30th June 2026 results

    Company Update / General View filing →

  24. 13 August 2026 ·

    General

    AGM And Important Dates

    AGM and other dates related to AGM and Voting

    Company Update / General View filing →

  25. 13 August 2026 ·

    General

    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Business And Strategic Updates

    Business Updates

    Company Update / General View filing →

  26. 13 August 2026 ·

    Results

    Financial Results For Quarter Ended On 30Th June 2026

    Financial Results and LRR

    Result / Financial Results View filing →

  27. 13 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On 13 August 2026

    Outcome of Board Meeting for quarterly financial results, AGM and appointment of auditors

    Board Meeting / Outcome of Board Meeting View filing →

  28. 10 August 2026 ·

    General

    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Receipt Of Manufacturing License For Biomescan Analytics Platform

    Manufacturing license for Biomescan Analytics Platform

    Company Update / General View filing →

  29. 6 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On August 06, 2026

    Outcome attached

    Board Meeting / Outcome of Board Meeting View filing →

  30. 28 July 2026 ·

    General

    Clarification To Shareholders And Investors Regarding Trading Status Of Equity Shares Under "Trading Restricted - On Account Of IRP As Per IBC / Recommencement Post IBC - IRP Stage-1"

    We would like to inform our shareholders and Investors that your company has represented its case to BSE as the said rule is not applicable to us. The Company has requested the exemption ....

    Company Update / General View filing →

  31. 24 July 2026 ·

    General

    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Submission Of Application For Listing And Trading Approval

    Application for Listing and Trading approval from NSE

    Company Update / General View filing →

  32. 24 July 2026 ·

    General

    Corrigendum To The Outcome Of Board Meeting - Allotment

    With Reference to the outcome of board Meeting Submitted on July 23, 2026 we wish to inform you that inadvertent typographical error the issue Price Consideration was mention is Rs-10 Per ....

    Company Update / General View filing →

  33. 23 July 2026 ·

    Allotment

    Allotment

    Allotment

    Company Update / Allotment of Equity Shares View filing →

  34. 21 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Board Meeting Intimation 13 August 2026

    Lords Mark Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Board Meeting intimation

    Board Meeting / Board Meeting View filing →

  35. 21 July 2026 ·

    KMP

    Resignation of Company Secretary / Compliance Officer

    Resignation of CS

    Company Update / Resignation of Company Secretary / Compliance Officer View filing →

  36. 20 July 2026 ·

    Order / Contract

    Award_of_Order_Receipt_of_Order

    Corporate announcement for work order

    Company Update / Award of Order / Receipt of Order View filing →

RSS feed for Lords Mark Industries Ltd · the 50 most recent filings